Blackstone to Buy Clarus as It Jumps Into Life Sciences

Blackstone Group has agreed to buy Clarus, an investment firm focused on life sciences, to serve as a platform for future acquisitions and partnerships in an area it thinks lacks access to capital.

from WSJ.com: US Business https://ift.tt/2xX4rUd
via IFTTT